Jeremy Joseph

SPARK Advisor

2019 - Current

Adviser to Stanford's center for translational research, helping create the next generation of therapeutics.

Biotech/Agtech VC Investor

2019

Data Collective (DCVC) is the first venture capital firm in Silicon Valley to invest exclusively in entrepreneurs building companies based on Big Data and deep compute. Advances in genetic sequencing, artificial intelligence and automation are converging to transform existing life sciences technologies and speed the development of new ones. We are looking for companies affecting deep technological change in synthetic biology, medicine, and agriculture. We have invested in Frontier Medicines (Drug Discovery & Chemoproteomics), Abcellera (Next-Gen Antibodies), GenEdit (Gene Therapy Delivery), Pivot Bio (Agriculture), Blue River (Agriculture robots), Atomwise (Drug Discovery & AI) and more... https://www.dcvc.com

Member

2019

Sloan Fellow at Stanford Graduate School of Business, MS in Business & Management

2018 - 2019

DCVC Bio Venture Scholar Co-Lead Stanford Impact Investment Fund GSB Student-Alumni Committee Liaison Cardinal Pitch Club Scout Independent Study with Professor Sarah Soule

Strategy Manager

2015 - 2018

Stanford Graduate School of Business - Executive Leadership Program (2017) Above & Beyond Winner - (2016) Finalist for CBO ACE Awards 2017 - Empowered Partnership Nominated for ACE Awards (2016 & 2017)- Nominated for Marketing Excellence Award (2017) - Alecensa Nominated for F&BAer of the Quarter (1Q16)

Healthcare Venture Capital Investor in Digital Health, Medical Devices & Life Sciences

2014 - 2015

Deal Teams: Evidation Health: GE Ventures’ first healthcare NewCo RainDance Technologies: $18.5M Series E Chrono Therapeutics: $32M Series A Talks StartOut (GE Ventures), Biotech – The Other Silicon Valley Tech (Panelist, 2014) Energizing Health Houston (GE Ventures), Texas Medical Accelerator Center Launch (Panelist, 2014)

Senior Associate (U.S. Pharmaceuticals Equity Research/Investment Banking)

2012 - 2014

Nominated for Above & Beyond Associate by Sales & Trading (June 2013) and featured on Credit Suisse Alumni Website for professional excellence (August 2012) Selected for Top 10 Thought Pieces of 2012 in Equity Research Department - “Deep Dive into Genomic Medicine” Developed research reports that provided investment insights on biotech drugs and life sciences tools for investment

Associate

2011 - 2012

Associate GCM

2010 - 2011

Fellow

2008 - 2009